Lamin Type A
Lamin Type B
Lamins
Nuclear Lamina
Nuclear Envelope
Progeria
Thymopoietins
Muscular Dystrophy, Emery-Dreifuss
Nuclear Proteins
Cell Nucleus
Lipodystrophy
Lipodystrophy, Familial Partial
Aging, Premature
Nuclear Matrix
Protein Prenylation
Caspase 6
Subcellular localization and partial purification of prelamin A endoprotease: an enzyme which catalyzes the conversion of farnesylated prelamin A to mature lamin A. (1/572)
The nuclear lamina protein, lamin A is produced by proteolytic cleavage of a 74 kDa precursor protein, prelamin A. The conversion of this precursor to mature lamin A is mediated by a specific endoprotease, prelamin A endoprotease. Subnuclear fractionation indicates that the prelamin A endoprotease is localized at the nuclear membrane. The enzyme appears to be an integral membrane protein, as it can only be removed from the nuclear envelope with detergent. It is effectively solubilized by the detergent n-octyl-beta-D-glucopyranoside and can be partially-purified (approximately 1200-fold) by size exclusion and cation exchange (Mono S) chromatography. Prelamin A endoprotease from HeLa cells was eluted from Mono S with 0.3 M sodium chloride as a single peak of activity. SDS-PAGE analysis of this prelamin A endoprotease preparation shows that it contains one major polypeptide at 65 kDa and smaller amounts of a second 68 kDa polypeptide. Inhibition of the enzyme activity in this preparation by specific serine protease inhibitors is consistent with the enzyme being a serine protease. (+info)Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy. (2/572)
Emery-Dreifuss muscular dystrophy has some remarkably specific features, with only cardiac and skeletal tissues being affected. Equally remarkably, the disease is caused by mutations in widely expressed genes for the nuclear membrane/lamina proteins, emerin and lamin A/C. How do mutations in proteins at the heart of the cell lead to stiff joints and sudden heart failure? This and related questions are the subject of this review. (+info)Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. (3/572)
The behavior of chimeric proteins consisting of A-type lamins and green fluorescent protein (GFP) was studied to investigate the localization and dynamics of nuclear lamins in living cells. Cell line CHO-K1 was transfected with cDNA constructs encoding fusion proteins of lamin A-GFP, lamin Adelta10-GFP, or lamin C-GFP. In the interphase nucleus lamin-GFP fluorescence showed a perinuclear localization and incorporation into the lamina for all three constructs. Our findings show for the first time that the newly discovered lamin A 10 protein is localized to the nuclear membrane. The GFP-tagged lamins were processed and behaved similarly to the endogenous lamin molecules, at least in cells that expressed physiological levels of the GFP-lamins. In addition to the typical perinuclear localization, in the majority of transfected cells each individual A-type lamin-GFP revealed an extensive collection of branching intra- and trans-nuclear tubular structures, which showed a clear preference for a vertical orientation. Time-lapse studies of 3-D reconstructed interphase cells showed a remarkable stability in both number and location of these structures over time, while the lamina showed considerable dynamic movements, consisting of folding and indentation of large parts of the lamina. Fluorescence recovery after bleaching studies revealed a low protein turnover of both tubular and lamina-associated lamins. Repetitive bleaching of intranuclear areas revealed the presence of an insoluble intranuclear fraction of A-type lamins. Time-lapse studies of mitotic cells showed that reformation of the lamina and the tubular structures consisting of A-type lamins did not occur until after cytokinesis was completed. (+info)Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. (4/572)
BACKGROUND: Altered expression of lamins A/C and B1, constituent proteins of the nuclear lamina, may occur during differentiation and has also been reported in primary lung cancer. AIMS: To examine the expression of these proteins in gastrointestinal neoplasms. PATIENTS: Archival human paraffin wax blocks and frozen tissue from patients undergoing surgical resection or endoscopic biopsy. METHODS: Immunohistochemistry and western blotting using polyclonal antisera against A type lamins and lamin B1. RESULTS: The expression of lamin A/C was reduced and was frequently undetectable by immunohistochemistry in all primary colon carcinomas and adenomas, and in 7/8 primary gastric cancers. Lamin B1 expression was reduced in all colon cancers, 16/18 colonic adenomas, and 6/8 gastric cancers. Aberrant, cytoplasmic labelling with both antibodies occurred in some colonic cancers and around one third of colonic adenomas. Cytoplasmic lamin A/C expression was detected in 3/8 gastric cancers. Lamin expression was reduced in gastric dysplasia, but not intestinal metaplasia, atrophy, or chronic gastritis. Lamin expression was low in carcinomas of oesophagus, prostate, breast, and uterus, but not pancreas. CONCLUSIONS: Reduced expression of nuclear lamins, sometimes together with aberrant, cytoplasmic immunoreactivity is common in gastrointestinal neoplasms. Altered lamin expression may be a biomarker of malignancy in the gastrointestinal tract. (+info)Colocalization of intranuclear lamin foci with RNA splicing factors. (5/572)
The lamins form a fibrous network underlying the inner nuclear membrane termed the nuclear lamina. In order to gain insights into the role of lamins in nuclear organization, we have characterized a monoclonal antibody (LA-2H10) raised against recombinant rat lamin A that labels nuclei in a speckled pattern in all cells of unsynchronized populations of HeLa and rat F-111 fibroblast cells, unlike the typical nuclear periphery staining by another monoclonal antibody to lamin A, LA-2B3. In immunolocalization studies the lamin A speckles or foci were found to colocalize with the RNA splicing factors SC-35 and U5-116 kD, but not with p80 coilin found in coiled bodies. Lamin B1 was also associated with these foci. These foci dispersed when cells entered mitosis and reformed during anaphase. The differential reactivity of LA-2H10 and LA-2B3 was retained after nuclei were extracted with detergents, nucleases and salt to disrupt interactions of lamins with chromatin and other nuclear proteins. Using deletion fragments of recombinant lamin A, the epitope recognized by LA-2H10 was located between amino acids 171 and 246. Our findings are consistent with a structural role for lamins in supporting nuclear compartments containing proteins involved in RNA splicing. (+info)Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. (6/572)
BACKGROUND: Inherited mutations cause approximately 35 percent of cases of dilated cardiomyopathy; however, few genes associated with this disease have been identified. Previously, we located a gene defect that was responsible for autosomal dominant dilated cardiomyopathy and conduction-system disease on chromosome 1p1-q21, where nuclear-envelope proteins lamin A and lamin C are encoded by the LMNA (lamin A/C) gene. Mutations in the head or tail domain of this gene cause Emery-Dreifuss muscular dystrophy, a childhood-onset disease characterized by joint contractures and in some cases by abnormalities of cardiac conduction during adulthood. METHODS: We evaluated 11 families with autosomal dominant dilated cardiomyopathy and conduction-system disease. Sequences of the lamin A/C exons were determined in probands from each family, and variants were confirmed by restriction-enzyme digestion. The genotypes of the family members were ascertained. RESULTS: Five novel missense mutations were identified: four in the alpha-helical-rod domain of the lamin A/C gene, and one in the lamin C tail domain. Each mutation caused heritable, progressive conduction-system disease (sinus bradycardia, atrioventricular conduction block, or atrial arrhythmias) and dilated cardiomyopathy. Heart failure and sudden death occurred frequently within these families. No family members with mutations had either joint contractures or skeletal myopathy. Serum creatine kinase levels were normal in family members with mutations of the lamin rod but mildly elevated in some family members with a defect in the tail domain of lamin C. CONCLUSIONS: Genetic defects in distinct domains of the nuclear-envelope proteins lamin A and lamin C selectively cause dilated cardiomyopathy with conduction-system disease or autosomal dominant Emery-Dreifuss muscular dystrophy. Missense mutations in the rod domain of the lamin A/C gene provide a genetic cause for dilated cardiomyopathy and indicate that this intermediate filament protein has an important role in cardiac conduction and contractility. (+info)Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. (7/572)
BACKGROUND: Dilated cardiomyopathy is a form of heart muscle disease characterized by impaired systolic function and ventricular dilation. Familial transmission of the disease is frequently observed, and genetic heterogeneity is indicated by clinical and morphological variability in the disease phenotype. In the family MDDC1 reported here, the disease phenotype is severe and characterized by an autosomal dominant pattern of transmission. In addition, the majority of affected family members show signs of mild skeletal muscle involvement. METHODS AND RESULTS: On the basis of the clinical observation of both cardiac and skeletal muscle abnormalities in the MDDC1 family, the lamin A/C gene was examined in this kindred. Coding regions were polymerase chain reaction-amplified from genomic DNA and sequenced. A single nucleotide deletion was identified within exon 6, and all affected individuals were found to be heterozygous for this deletion. CONCLUSIONS: Heterozygosity for a single nucleotide deletion in exon 6 of lamin A/C segregates with both the cardiac and skeletal abnormalities observed in the MDDC1 family. (+info)DNase I hypersensitive sites and transcriptional activation of the lamin A/C gene. (8/572)
The lamin A/C gene encodes subtypes of nuclear lamins, which are involved in nuclear envelope formation, and was recently identified as the responsible gene for the autosomal dominant Emery-Dreifuss muscular dystrophy. Expression of the lamin A/C gene is developmentally regulated but little is known about the regulatory mechanism. Previous studies of lamin A/C expression suggested that the chromatin structure is important for the regulation of its expression. To elucidate the regulatory mechanism of the lamin A/C gene expression, we have analysed the functional region of the mouse lamin A/C promoter and the chromatin structure of the gene in terms of nucleosome structure and DNase I hypersensitivity. Our analyses revealed disruption of the nucleosome array at the promoter region and the presence of multiple DNase I hypersensitive sites (HSs) which were specifically associated with expression of the lamin A/C gene. Inclusion of a segment which contained the HSs in a lamin A/C promoter-luciferase reporter plasmid showed no effect on the transfected promoter activity in transient expression assays. On the other hand, substantial enhancement of the promoter activity was detected when the transfected DNA was stably integrated into the genome, suggesting the importance of the HSs in the regulation of lamin A/C expression. (+info)The main symptoms of progeria include:
1. Rapid growth and development during the first two years of life, followed by slowed growth and loss of fat and muscle mass.
2. A distinctive facial appearance, including a small face, thin nose, and narrow eyes.
3. Wasting of the skin, hair, and joints.
4. Cardiovascular disease, such as hardening of the arteries and heart problems.
5. Osteoporosis and joint degeneration.
6. Respiratory problems, including frequent colds and difficulty breathing.
7. Eye problems, including cataracts and glaucoma.
8. Increased risk of stroke and other cardiovascular complications.
Progeria is a fatal condition, with most children dying from heart disease or stroke before the age of 21. However, some individuals with progeria have been known to live into their 30s or 40s due to advances in medical care and technology. There is currently no cure for progeria, but researchers are working to develop new treatments to slow down the progression of the disease and improve the quality of life for those affected.
The symptoms of Emery-Dreifuss muscular dystrophy usually become apparent during childhood or adolescence and may include:
* Muscle weakness and wasting
* Delayed motor development
* Frequent falls
* Muscle cramps
* Heart problems (cardiomyopathy)
* Cognitive impairment
The disorder is inherited in an X-linked recessive pattern, meaning that the mutated gene is located on the X chromosome and affects males more severely than females. Females can be carriers of the disorder and may have mild symptoms or be unaffected.
Emery-Dreifuss muscular dystrophy is diagnosed through a combination of clinical evaluation, genetic testing, and muscle biopsy. There is no cure for the disorder, but various treatments can help manage the symptoms and slow its progression. These may include:
* Physical therapy to maintain muscle strength and function
* Medications to control muscle spasms and cramps
* Heart medications to manage cardiomyopathy
* Assistive devices such as braces or wheelchairs
The progression of Emery-Dreifuss muscular dystrophy can vary widely among individuals, with some experiencing a rapid decline in muscle function while others may remain relatively stable for many years. Life expectancy is typically reduced due to the risk of complications such as heart failure and respiratory failure.
In summary, Emery-Dreifuss muscular dystrophy is a rare and debilitating genetic disorder that affects the muscles and can lead to progressive weakness, wasting, and loss of motor function. While there is no cure for the disorder, various treatments can help manage its symptoms and slow its progression. Early diagnosis and ongoing medical management are essential to improve quality of life and reduce the risk of complications.
Lipodystrophy can be caused by genetic mutations, hormonal imbalances, or certain medications. It can also be associated with other medical conditions such as metabolic disorders, endocrine problems, and neurological diseases.
The symptoms of lipodystrophy can vary depending on the type and severity of the condition. Common symptoms include:
1. Muscle wasting and weakness
2. Fat redistribution to certain areas of the body (such as the face, neck, and torso)
3. Metabolic problems such as insulin resistance and high blood sugar
4. Hormonal imbalances
5. Abnormal body shape and proportions
6. Poor wound healing
7. Easy bruising and bleeding
8. Increased risk of infections
9. Joint pain and stiffness
10. Mood changes such as depression, anxiety, and irritability
Treatment for lipodystrophy depends on the underlying cause of the condition. Medications, lifestyle modifications, and surgery may be used to manage symptoms and improve quality of life. In some cases, lipodystrophy can be a sign of an underlying medical condition that needs to be treated.
Lipodystrophy can have a significant impact on an individual's quality of life, affecting their physical appearance, self-esteem, and ability to perform daily activities. It is important to seek medical attention if symptoms persist or worsen over time. With proper diagnosis and treatment, individuals with lipodystrophy can improve their symptoms and overall health.
[Note: This definition is a summary and an explanation of the term 'Lipodystrophy, Familial Partial' in the medical field.]
There are several types of premature aging, including:
1. Progeria: This is a rare genetic condition that causes accelerated aging in children, resulting in a shortened life span.
2. Hutchinson-Gilford progeria syndrome: This is the most common form of progeria, which affects approximately 1 in 4 million children worldwide. Children with this condition typically die before reaching their teenage years due to complications such as heart attack or stroke.
3. Wiedemann-Steiner syndrome: This is a rare genetic disorder that causes premature aging, including wrinkled skin, thinning hair, and joint stiffness.
4. Werner syndrome: This is a rare genetic disorder that affects approximately 1 in 250,000 individuals worldwide. It is characterized by premature aging, including grey hair, wrinkled skin, and a high risk of developing cancer and other age-related diseases.
5. Telomere shortening: Telomeres are the protective caps at the end of chromosomes that shorten with each cell division. Premature telomere shortening can lead to accelerated aging and an increased risk of age-related diseases.
6. Chronic stress: Prolonged exposure to chronic stress can lead to premature aging, including changes in the brain, skin, and immune system.
7. Poor nutrition: A diet lacking essential nutrients can lead to premature aging, including vitamin D deficiency, which is associated with an increased risk of osteoporosis and other age-related diseases.
8. Lack of exercise: Physical inactivity can contribute to premature aging, including decreased muscle mass, bone density, and cognitive function.
9. Smoking: Cigarette smoking is a significant risk factor for premature aging, including wrinkles, age spots, and an increased risk of cancer and cardiovascular disease.
10. Alcohol consumption: Excessive alcohol consumption can lead to premature aging, including liver damage, heart disease, and certain types of cancer.
While many of these factors are beyond our control, there are steps we can take to reduce their impact and promote healthy aging. These include maintaining a balanced diet, exercising regularly, getting enough sleep, managing stress, not smoking, and limiting alcohol consumption. Additionally, staying up-to-date on preventative healthcare measures, such as regular check-ups and screenings, can help identify and address any potential health issues before they become more serious.
Lamin B1
Lamin
Lamin B receptor
Lamin B2
Intermediate filament
MLIP (gene)
Thymopoietin
ANKRD2
Senescence
MAP1LC3B
Progeria
Neurofilament
Nuclear lamina
DNA damage theory of aging
ZMPSTE24
Progeroid syndromes
Disposable soma theory of aging
LMNA-related congenital muscular dystrophy
Laminopathy
Evolution of ageing
Crescentin
Prenylation
Fluorescence-lifetime imaging microscopy
Inner nuclear membrane protein
TOR1AIP1
Nuclear prelamin A recognition factor
Cell nucleus
Nestin (protein)
Barrier to autointegration factor 1
Abdul Majid Giaka
Familial partial lipodystrophy
Histone H2B
Code of Personal Status in Tunisia
Christian influences on the Islamic world
Walpurgis Night
Abuko Nature Reserve
Atrial fibrillation
Mitosis
Stem cell marker
Nuclear matrix
Clergy
Histone acetyltransferase
Mende people
Sierra Leone
List of MeSH codes (D12.776.660)
Dilated cardiomyopathy
Soninke people
Romanov Empire (micronation)
Florent Cuvelier
TM7SF2
A-type lamin-linked lipodystrophies - PubMed
Lamin B1 resource search results | Abcam
Lamin A-dependent nuclear defects in human aging - PubMed
A-type lamins involvement in transport and implications in cancer? | Nucleus;13(1): 221-235, 2022 12. | MEDLINE
The gene structure of Xenopus nuclear lamin A: a model for the evolution of A-type from B-type lamins by exon shuffling. :: MPG...
NIH Guide: THE BIOLOGICAL BASIS OF HUTCHINSON-GILFORD SYNDROME (HGS): RELATIONSHIP TO MUTATIONS IN THE LAMIN A/C GENE (LMNA)...
Genome-wide analysis links emerin to neuromuscular junction activity in Caenorhabditis elegans
Linear Ironwood 3118 Premium Wood Prints Laminate
Emery-Dreifuss Muscular Dystrophy Workup: Laboratory Studies, Other Tests, Procedures
MedlinePlus: Genes: L
Emery-Dreifuss Muscular Dystrophy Medication
Biomarkers Search
p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases | Nature...
maturity-onset diabetes of the young - Ontology Report - Rat Genome Database
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy | Journal of Medical Genetics
MedlinePlus - Search Results for: "Adult-onset" autosomal dominant demyelinating leukodystrophy
Microglia Cross Module Antibody Sampler Kit | Cell Signaling Technology
MeSH Browser
Research - Forbes Porter Lab | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development
Biomarkers Search
LMNB2
- Early...
Hutchinson-Gilford progeria syndrome: MedlinePlus Genetics
Publications
Ryan Nitta's Profile | Stanford Profiles
Type of Grants | The African Capacity Building Foundation
Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrest - Fingerprint
- Research Profiles at...
Leukodystrophy | National Institute of Neurological Disorders and Stroke
LMNA9
- At the genetic level, LMNA mutations concern in most cases the type-A lamin C-terminal domain and more than 80% are heterozygous substitutions located at position 482 (R482W/Q/L). The other locations are G465D, K486N, R582H and R584H. (nih.gov)
- 2002). These disorders and their relationship to LMNA mutations have been reviewed recently {Burke and Stewart (2002)}, and Hutchinson (2002) has reviewed the function of lamins in the nuclear envelope. (nih.gov)
- 2002. Homozygous defects in LMNA, encoding lamin A/C nuclear envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. (nih.gov)
- 2002. Mandibuloacural dysplasia is caused by a mutation in LMNA encoding lamin A/C. Am. J. Hum. (nih.gov)
- 2000. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. (nih.gov)
- 9. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations. (nih.gov)
- 16. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N). (nih.gov)
- Western blot analysis of extracts from control HeLa cells (lane 1) or HeLa cells with an apparent in-frame truncation mutation in the gene encoding LMNA (lane 2) using Lamin A/C (4C11) Mouse mAb #4777 (upper) or α-actinin (D6F6) XP ® Rabbit mAb #6487 (lower). (cellsignal.com)
- The LMNA gene provides instructions for making a protein called lamin A. This protein plays an important role in determining the shape of the nucleus within cells. (nih.gov)
Mutations18
- Mutations in the nuclear structural protein lamin A cause the premature aging syndrome Hutchinson-Gilford progeria (HGPS). (nih.gov)
- lamin C is a splice variant and lacks the carboxyl terminus present in lamin A. At least 6 other rare human disorders due to lamin A/C mutations (known collectively as laminopathies) besides HGS have been described so far: Emery-Dreifuss muscular dystrophy (Bonne et al. (nih.gov)
- RESEARCH OBJECTIVES Lamin A is a major component of the nuclear envelope, so mutations in this gene are likely to have a broad impact on both nuclear structure and function. (nih.gov)
- o Develop interventions to reverse or attenuate cellular dysfunction due to lamin A mutations. (nih.gov)
- 1999. Mutations in the gene coding lamin A/C cause autosomal dominant muscular dystrophy. (nih.gov)
- 1999. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated myopathy and conduction system disease. (nih.gov)
- 2000. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances. (nih.gov)
- A well-known example is Emery-Dreifuss muscular dystrophy, which is caused by mutations in the human lamin A/C and emerin genes. (nih.gov)
- 2. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. (nih.gov)
- 5. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. (nih.gov)
- 7. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. (nih.gov)
- 14. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. (nih.gov)
- The unique caused by mutations in the lamin A/C gene localization of emerin in desmosomes and on chromosome 1 (1q11-q23) [ 3 ]. (who.int)
- Vertebrate lamins consist of two types, A and B. Mutations in this gene are associated with acquired partial lipodystrophy. (nih.gov)
- Mutations that cause Hutchinson-Gilford progeria syndrome result in the production of an abnormal version of the lamin A protein. (nih.gov)
- Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. (nih.gov)
- The disorder is caused by mutations in the LMNB1 gene which is responsible for making lamin B1 protein. (nih.gov)
- Insulin-resistance syndromes include those with mutations in the insulin receptors (ie, leprechaunism, Rabson-Mendenhall syndrome), peroxisome proliferator-activated receptor gamma (ie, type 1 diabetes with acanthosis nigricans and hypertension), 1-acylglycerol-3-phosphate O-acyl transferase-2 or seipin (Berardinelli-Seip syndrome), lamin A/C (Dunnigan syndrome), and Alstrom syndrome gene. (medscape.com)
Proteins8
- o Determine the cell-specific functions of the lamins in cells of the cardiovascular system, such as endothelial cells and cardiac and vascular smooth muscle cells, and the molecular mechanisms through which these proteins control and regulate cellular function. (nih.gov)
- The lamin family of proteins make up the matrix and are highly conserved in evolution. (nih.gov)
- During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. (nih.gov)
- Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. (nih.gov)
- Each type of leukodystrophy is caused by a defect in one of the genes that control the structure or amount of one of the proteins or lipids in myelin. (nih.gov)
- Lamin B1 is a structural protein that helps determine the shape of the cell nucleus and plays an important role in cell division and gene expression, including expression of the genes for oligodendrocyte development and production of some myelin proteins. (nih.gov)
- In this work, three motifs, the nuclear localization signal (NLS), the CAAX motif, and the 42 AA insert, specific to lamin proteins, were studied as to their role in targeting and assembly. (umaryland.edu)
- Biochemical analysis of the cell lines indicated that a large portion of lamin B does not co-fractionate with its putative receptor (p58), suggesting that the two proteins do not bind directly with one another. (umaryland.edu)
Developmentally regulated1
- A subclass of developmentally regulated lamins having a neutral isoelectric point. (nih.gov)
Partial lipodystrophy2
- Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. (medscape.com)
- 4. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. (nih.gov)
Hutchinson-Gilford3
- Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. (nih.gov)
- Gonzalez JM, Pla D, Perez-Sala D, Andres V. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy. (nih.gov)
- In 2003 his team identified Lamin A as the gene whose mutation is responsible for the extreme accelerated aging phenotype observed in Hutchinson-Gilford progeria patients. (nih.gov)
Lamina2
- The stability of the lamin B1 lamina is dependent on lamin endoproteolysis (by Rce1) but not carboxymethylation (by Icmt), whereas lamin C lamina stability is not affected by the loss of full-length lamin B1 or its processing. (ox.ac.uk)
- Comparison of wild-type murine fibroblasts with fibroblasts lacking full-length lamin B1, or defective in CAAX processing, identified genes that depend on a stable processed lamin B1 lamina for normal expression. (ox.ac.uk)
Chromatin1
- We further demonstrate that, in differentiating myoblasts, nuclear HSPB2 compartments sequester lamin A. Increasing the nuclear concentration of HSPB2 causes the formation of aberrant nuclear compartments that mislocalize lamin A and chromatin, with detrimental consequences for nuclear function and integrity. (rug.nl)
Implicate2
Berardinelli-Seip1
- Generalised lipodystrophy of the Berardinelli-Seip type (BSCL) is a rare autosomal recessive human disorder with severe adverse metabolic consequences. (bmj.com)
Mutation1
- 8. Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation. (nih.gov)
Defects3
- Age-related nuclear defects are caused by sporadic use, in healthy individuals, of the same cryptic splice site in lamin A whose constitutive activation causes HGPS. (nih.gov)
- Other human malformation syndromes caused by inborn errors of cholesterol synthesis include Lathosterolosis, Desmosterolosis, X-linked dominant chondrodysplasia punctata type 2 (CDPX2), and Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects (CHILD syndrome). (nih.gov)
- Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression. (ox.ac.uk)
Progeria1
- Ghosh S, Zhou Z. Genetics of aging, progeria and lamin disorders. (nih.gov)
Exon1
- The gene structure of Xenopus nuclear lamin A: a model for the evolution of A-type from B-type lamins by exon shuffling. (mpg.de)
CAAX3
- The NLS is believed to target lamins to the nucleus while the CAAX motif acts to confer association of lamins with the nuclear envelope. (umaryland.edu)
- Stable cell lines expressing lamin B either with or without a CAAX motif were created. (umaryland.edu)
- Overexpression of lamin mutants lacking a CAAX motif resulted in accumulation into multiple aggregates within the nucleus that did not colocalize with coiled bodies. (umaryland.edu)
Gene expression2
20001
- 2000), Charcot-Marie-Tooth disorder type 2 (De Sandre-Giovanni et al. (nih.gov)
Muscular dystrophy1
- In a study utilizing MRI imaging, researchers found that all patients with Emery-Dreifuss muscular dystrophy type 2 showed a characteristic involvement of the posterior calf muscles. (medscape.com)
Phenotype1
- Long filaments were formed with cytoplasmic head domains were present on lamin rods, but the converse phenotype of reticular filaments formed whenever the lamin head domain was present. (umaryland.edu)
Genes1
- Despite widespread loss of cytosine methylation at regulatory sites, including promoter regions of protein coding genes and non-coding RNA genes, overall transcript abundance levels in the Hells-/- are similar to those in wild type cells. (nih.gov)
Nucleus2
- A multitude of complex, coupled interactions between lamins and nucleoporins (Nups), which mediate active transport into and out of the nucleus, combined with well documented dysregulation of lamins in many cancers , suggests that lamins and nuclear transport may play a pivotal role in carcinogenesis and the preservation of cancer . (bvsalud.org)
- Lamin B mutants deleted of any one of the three motifs showed delayed but appropriate targeting to the nucleus. (umaryland.edu)
Disorders1
- Smith-Lemli-Opitz syndrome (SLOS) and Niemann-Pick disease, type C1 (NPC1), respectively, are the prototypical examples of cholesterol homeostatic disorders whereas Juvenal Battens disease (CLN3) is an example of a lysosomal disease with unknown protein function. (nih.gov)
Interactions1
- o Determine how changes in the nuclear interactions of the lamins contribute to cardiovascular disease. (nih.gov)
Involvement1
- A-type lamins involvement in transport and implications in cancer? (bvsalud.org)
Leukodystrophy3
- the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). (nih.gov)
- Symptoms of leukodystrophy vary according to the specific type and may be difficult to recognize in the early stages of the disorder. (nih.gov)
- Each type of leukodystrophy affects myelin differently and in different parts of the CNS, leading to a range of symptoms. (nih.gov)
Generate1
- Much of the early energy and enthusiasm passed instead to research into cellular reprogramming, such as that involved in the creation of induced pluripotent stem cells that can be used to generate any type of cells on demand. (fightaging.org)
Damage1
- Changes of function related to lamin /Nup activity can principally lead to DNA damage , further increasing the genetic diversity within a tumor , which could lead to the reduction the effectiveness of antineoplastic treatments . (bvsalud.org)
Role5
- Whether lamin A plays any role in normal aging is unknown. (nih.gov)
- This review discusses and synthesizes different connections of lamins to nuclear transport and offers a number of outlook questions, the answers to which could reveal a new perspective on the connection of lamins to molecular transport of cancer therapeutics , in addition to their established role in nuclear mechanics . (bvsalud.org)
- o Characterize age-related changes in lamins and the nuclear envelope, and determine whether these play any role in development of adverse phenotypes during normal aging. (nih.gov)
- Chimeric molecules were also created from the cytoplasmic IF, NF-L, and lamin to further test the role of other IF domains in assembly and sorting. (umaryland.edu)
- We report here a role for Hells in the establishment of cytosine methylation comprising a nuclear compartment that is in part defined by Lamin B1 attachment regions. (nih.gov)
Cells1
- Flow cytometric analysis of Daudi cells (blue) and MJ cells (green) using Lamin A/C (4C11) Mouse mAb (solid lines) or concentration-matched Mouse (G3A1) mAb IgG1 Isotype Control #5415 (dashed lines). (cellsignal.com)
Determine1
- Here we determine genome-wide DNA association profiles of two nuclear envelope components, lamin/LMN-1 and emerin/EMR-1 in adult Caenorhabditis elegans. (nih.gov)
Thought1
- The 42 AA insert is thought to inhibit association of lamins with their cytoplasmic counterparts. (umaryland.edu)